Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sinocelltech Group's book value per share for the quarter that ended in Mar. 2026 was ¥1.80.
During the past 12 months, Sinocelltech Group's average Book Value Per Share Growth Rate was 292.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Sinocelltech Group was 43.90% per year. The lowest was -107.70% per year. And the median was -24.20% per year.
Sinocelltech Group's current price is ¥36.46. Its book value per share for the quarter that ended in Mar. 2026 was ¥1.80. Hence, today's PB Ratio of Sinocelltech Group is 20.23.
During the past 10 years, the highest P/B Ratio of Sinocelltech Group was 343.01. The lowest was 18.31. And the median was 28.30.
Sinocelltech Group (SHSE:688520) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Sinocelltech Group Book Value per Share Related Terms
Sinocelltech Group Book Value per Share Historical Data
* Premium members only.
The historical data trend for Sinocelltech Group's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688520 vs VRTX, REGN, RVMD: Book Value per Share Comparison
For the Biotechnology subindustry, Sinocelltech Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinocelltech Group PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sinocelltech Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sinocelltech Group's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinocelltech Group (SHSE:688520) has a Book Value per Share of ¥1.80 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Sinocelltech Group and its competitors.
Is Sinocelltech Group's Book Value per Share too high?
Sinocelltech Group's current Book Value per Share is ¥1.80. Overall, Sinocelltech Group has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sinocelltech Group's Book Value per Share compare to VRTX and REGN?
Sinocelltech Group's Book Value per Share of ¥1.80 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Sinocelltech Group and its competitors. Sinocelltech Group's current Book Value per Share is ¥1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinocelltech Group stock overvalued right now?
Based on GuruFocus' analysis, Sinocelltech Group (SHSE:688520) is currently considered Fairly Valued. The stock's GF Value™ is ¥36.98, compared to a current price of ¥36.46 — trading 1.4% below its estimated fair value. The current Book Value per Share is ¥1.80. Sinocelltech Group's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Sinocelltech Group (SHSE:688520), the current Book Value per Share is ¥1.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinocelltech Group (SHSE:688520) Overvalued in 2026?
Based on GuruFocus' analysis, Sinocelltech Group stock appears to be undervalued.
The current stock price of ¥36.46 is trading 1.4% below its estimated GF Value™ of ¥36.98.
GuruFocus considers Sinocelltech Group to be Fairly Valued.
Key valuation signals for SHSE:688520:
Book Value per Share: ¥1.80
GF Value™: ¥36.98 vs. price of ¥36.46 (1.4% below fair value)
No single metric tells the full story. See the SHSE:688520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinocelltech Group Ltd is one of Chin's biopharma companies specializing in biologics and vaccines. The company's therapeutic areas include oncology, immunology and inflammation, ophthalmology, and prophylactic vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The capabilities of the company include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up, protein purification development, and large scale production.
64GF Score
Get the complete analysis for SHSE:688520
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688520 has been successfully added to your 
